Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies
- PMID: 28686188
- PMCID: PMC5537826
- DOI: 10.3390/nu9070711
Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies
Abstract
Studies implicate choline and betaine metabolite trimethylamine N-oxide (TMAO) in cardiovascular disease (CVD). We conducted a systematic review and random-effects meta-analysis to quantify a summary estimated effect of dietary choline and betaine on hard CVD outcomes (incidence and mortality). Eligible studies were prospective studies in adults with comprehensive diet assessment and follow-up for hard CVD endpoints. We identified six studies that met our criteria, comprising 18,076 incident CVD events, 5343 CVD deaths, and 184,010 total participants. In random effects meta-analysis, incident CVD was not associated with choline (relative risk (RR): 1.00; 95% CI: 0.98, 1.02) or betaine (RR: 0.99; 95% CI: 0.98, 1.01) intake. Results did not vary by study outcome (incident coronary heart disease, stroke, total CVD) and there was no evidence for heterogeneity among studies. Only two studies provided data on phosphatidylcholine and CVD mortality. Random effects meta-analysis did not support an association between choline and CVD mortality (RR: 1.09, 95% CI: 0.89, 1.35), but one study supported a positive association and there was significant heterogeneity (I² = 84%, p-value < 0.001). Our findings do not support an association between dietary choline/betaine with incident CVD, but call for further research into choline and CVD mortality.
Keywords: betaine; cardiovascular disease; choline; epidemiology; meta-analysis; systematic review.
Conflict of interest statement
K.A.M. received a research grant from the Egg Nutrition Center (ENC) in 2015–2016. The ENC grant supported work distinct from the present paper, though eggs are a choline-rich food and the findings of this meta-analysis relate to the general research mission of the ENC. J.W.S. declares no conflict of interest.
Figures
Similar articles
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Beta-blockers for hypertension.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. doi: 10.1002/14651858.CD002003.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002003. doi: 10.1002/14651858.CD002003.pub3. PMID: 17253471 Updated.
-
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.Cochrane Database Syst Rev. 2021 Oct 25;10(10):CD013650. doi: 10.1002/14651858.CD013650.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693515 Free PMC article.
-
Patient education in the management of coronary heart disease.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3. Cochrane Database Syst Rev. 2017. PMID: 28658719 Free PMC article.
Cited by
-
Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.PLoS One. 2021 Mar 3;16(3):e0244402. doi: 10.1371/journal.pone.0244402. eCollection 2021. PLoS One. 2021. PMID: 33657115 Free PMC article.
-
Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds.Front Mol Biosci. 2022 Aug 26;9:964624. doi: 10.3389/fmolb.2022.964624. eCollection 2022. Front Mol Biosci. 2022. PMID: 36310589 Free PMC article. Review.
-
The Effects of Alpha-Glycerylphosphorylcholine on Heart Rate Variability and Hemodynamic Variables Following Sprint Interval Exercise in Overweight and Obese Women.Nutrients. 2022 Sep 24;14(19):3970. doi: 10.3390/nu14193970. Nutrients. 2022. PMID: 36235623 Free PMC article. Clinical Trial.
-
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence.Curr Nutr Rep. 2024 Jun;13(2):152-165. doi: 10.1007/s13668-024-00521-3. Epub 2024 Mar 1. Curr Nutr Rep. 2024. PMID: 38427291 Free PMC article. Review.
-
Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis.Am J Clin Nutr. 2021 Sep 1;114(3):893-906. doi: 10.1093/ajcn/nqab152. Am J Clin Nutr. 2021. PMID: 34020444 Free PMC article.
References
-
- Tang W.H., Wang Z., Kennedy D.J., Wu Y., Buffa J.A., Agatisa-Boyle B., Li X.S., Levison B.S., Hazen S.L. Gut microbiota-dependent trimethylamine n-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 2015;116:448–455. doi: 10.1161/CIRCRESAHA.116.305360. - DOI - PMC - PubMed
-
- Tang W.H., Wang Z., Shrestha K., Borowski A.G., Wu Y., Troughton R.W., Klein A.L., Hazen S.L. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card Fail. 2015;21:91–96. doi: 10.1016/j.cardfail.2014.11.006. - DOI - PMC - PubMed
-
- Troseid M., Ueland T., Hov J.R., Svardal A., Gregersen I., Dahl C.P., Aakhus S., Gude E., Bjorndal B., Halvorsen B., et al. Microbiota-dependent metabolite trimethylamine-n-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 2015;277:717–726. doi: 10.1111/joim.12328. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous